HUP0400520A2 - Klindamicint és cinksót tartalmazó dermatológiai készítmények - Google Patents

Klindamicint és cinksót tartalmazó dermatológiai készítmények

Info

Publication number
HUP0400520A2
HUP0400520A2 HU0400520A HUP0400520A HUP0400520A2 HU P0400520 A2 HUP0400520 A2 HU P0400520A2 HU 0400520 A HU0400520 A HU 0400520A HU P0400520 A HUP0400520 A HU P0400520A HU P0400520 A2 HUP0400520 A2 HU P0400520A2
Authority
HU
Hungary
Prior art keywords
zinc
salt
formulations containing
clindamycin
dermatological formulations
Prior art date
Application number
HU0400520A
Other languages
English (en)
Inventor
Rebecca Louise Kanis
Emma Louise Mcdonagh
Original Assignee
Access Pharmaceuticals, Inc.
Kanford B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Access Pharmaceuticals, Inc., Kanford B.V. filed Critical Access Pharmaceuticals, Inc.
Publication of HUP0400520A2 publication Critical patent/HUP0400520A2/hu
Publication of HUP0400520A3 publication Critical patent/HUP0400520A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

A találmány tárgya dermatológiai készítmények. A találmány lényegébenekvimoláris mennyiségű cinksót és klindamicin-foszfátot tartalmazóvizes készítményekre vonatkozik, amelyek egy polimert képeznek, és ezta készítményt acne és rosacea kezelésére használhatják igen alacsonyklindamicin szisztemikus szint mellett. Ó
HU0400520A 2000-11-28 2001-11-28 Dermatological formulations containing clindamycin and a zinc-salt HUP0400520A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029018.9A GB0029018D0 (en) 2000-11-28 2000-11-28 Dermatological formulations
PCT/GB2001/005257 WO2002043739A2 (en) 2000-11-28 2001-11-28 Dermatological formulations containing clindamycin and a zinc-salt

Publications (2)

Publication Number Publication Date
HUP0400520A2 true HUP0400520A2 (hu) 2004-07-28
HUP0400520A3 HUP0400520A3 (en) 2012-08-28

Family

ID=9904040

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400520A HUP0400520A3 (en) 2000-11-28 2001-11-28 Dermatological formulations containing clindamycin and a zinc-salt

Country Status (25)

Country Link
US (2) US20040109902A1 (hu)
EP (1) EP1347765B1 (hu)
JP (1) JP4272425B2 (hu)
KR (1) KR100629326B1 (hu)
AT (1) ATE321560T1 (hu)
AU (2) AU2002223091B2 (hu)
BR (1) BR0115727A (hu)
CA (1) CA2429205C (hu)
CZ (1) CZ305272B6 (hu)
DE (1) DE60118441T2 (hu)
DK (1) DK1347765T3 (hu)
ES (1) ES2263689T3 (hu)
GB (1) GB0029018D0 (hu)
HK (1) HK1059218A1 (hu)
HR (1) HRP20030433B1 (hu)
HU (1) HUP0400520A3 (hu)
IL (1) IL152720A0 (hu)
MX (1) MXPA03004733A (hu)
NZ (1) NZ526170A (hu)
PL (1) PL207221B1 (hu)
PT (1) PT1347765E (hu)
RU (1) RU2277419C2 (hu)
SK (1) SK288111B6 (hu)
WO (1) WO2002043739A2 (hu)
ZA (1) ZA200305012B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
AU2006337161B2 (en) 2006-02-03 2012-06-07 Obagi Cosmeceuticals Llc Anti-aging treatment using copper and zinc compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
ES2386851T3 (es) * 2007-11-30 2012-09-03 Novartis Ag Alquil (C2-C5)-imidazol-bisfosfonatos
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
AU2010238566B2 (en) * 2010-11-01 2012-09-20 Stiefel Research Australia Pty Ltd Polymeric topical compositions
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
CN109498564B (zh) * 2018-12-21 2021-04-16 贵州景峰注射剂有限公司 一种克林霉素磷酸酯配液及其制备方法
US20230000892A1 (en) * 2021-06-30 2023-01-05 Kenneth Okafor Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4621075A (en) * 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
JPS6251619A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd 外用ゲル製剤
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
ATE281075T1 (de) * 1994-03-28 2004-11-15 Univ Columbia Zusammensetzung zum inaktivieren von reizstoffen in flüssigkeiten
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use

Also Published As

Publication number Publication date
AU2309102A (en) 2002-06-11
EP1347765A2 (en) 2003-10-01
US20100173855A1 (en) 2010-07-08
HUP0400520A3 (en) 2012-08-28
MXPA03004733A (es) 2005-02-14
SK288111B6 (sk) 2013-08-02
SK6322003A3 (en) 2003-12-02
HRP20030433A2 (en) 2004-08-31
HK1059218A1 (en) 2004-06-25
JP2004517829A (ja) 2004-06-17
DE60118441T2 (de) 2006-11-16
CZ20031491A3 (cs) 2004-01-14
DE60118441D1 (de) 2006-05-18
RU2277419C2 (ru) 2006-06-10
IL152720A0 (en) 2003-06-24
EP1347765B1 (en) 2006-03-29
US20040109902A1 (en) 2004-06-10
US8268790B2 (en) 2012-09-18
CZ305272B6 (cs) 2015-07-15
KR20030069793A (ko) 2003-08-27
HRP20030433B1 (en) 2007-10-31
ES2263689T3 (es) 2006-12-16
PT1347765E (pt) 2006-08-31
ATE321560T1 (de) 2006-04-15
ZA200305012B (en) 2005-04-26
CA2429205A1 (en) 2002-06-06
PL362279A1 (en) 2004-10-18
PL207221B1 (pl) 2010-11-30
DK1347765T3 (da) 2006-08-07
AU2002223091B2 (en) 2006-08-31
JP4272425B2 (ja) 2009-06-03
GB0029018D0 (en) 2001-01-10
KR100629326B1 (ko) 2006-09-29
BR0115727A (pt) 2003-10-14
CA2429205C (en) 2010-11-16
WO2002043739A2 (en) 2002-06-06
NZ526170A (en) 2006-01-27
WO2002043739A3 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
HUP0400520A2 (hu) Klindamicint és cinksót tartalmazó dermatológiai készítmények
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
NO20034323L (no) Medisinske aerosolformuleringer
BRPI0412029A (pt) formulações para microprojeções revestidas contendo contra-ìons não-voláteis
DE60106954D1 (de) Resorcin-derivate
CY1106319T1 (el) Τοπικη θepαπεια στη μασταλγια
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
TR200102958T2 (tr) Siklooksijenaz-2 inhibitörleri olarak 4,5-diaril-3(2H)-furanon türevleri.
AU2002223058A1 (en) Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling
ATE396745T1 (de) Complex enthaltend modafinil und cyclodextrin
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
DE602004031208D1 (de) Keratolytische zusammensetzung mit antiallergischen und entzündungshemmenden eigenschaften
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
DK1330244T3 (da) Præparater der omfatter modafinilforbindelser
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
WO2004039326A3 (en) Propofol with cysteine
ATE259813T1 (de) Triazolopyrimidinderivate
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
WO2004000372A3 (de) Desinfizierende zusammensetzung, daraus hergestellte reinigungstablette und deren verwendung
NO20054086L (no) Depigmenteringsmidler
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: STRAKAN INTERNATIONAL LIMITED, BM

Free format text: FORMER OWNER(S): KANFORD B.V., NL; ACCESS PHARMACEUTICALS, INC., US

FD9A Lapse of provisional protection due to non-payment of fees